Intravitreal Therapy for Diabetic Macular Edema: An Update
Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME represents a sight-threatening condition, it is also among the most accessible to treatment. Many different treatment options including photocoagulation, intravitreal medical treatment (either vascular...
Main Authors: | Claudio Furino, Francesco Boscia, Michele Reibaldi, Giovanni Alessio |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2021/6654168 |
Similar Items
-
Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
by: Claudio Furino, et al.
Published: (2020-10-01) -
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
by: Claudio Furino, et al.
Published: (2017-01-01) -
Efficacy and safety of intravitreal aflibercept therapy in diabetic macular edema
by: Ali Cihat Aslan, et al.
Published: (2019-06-01) -
Intravitreal bevacizumab and diabetic papillopathy with macular edema
by: Beuy Joob, et al.
Published: (2012-01-01) -
Intravitreal dexamethasone implants for diabetic macular edema
by: Alicia Pareja-Ríos, et al.
Published: (2018-01-01)